Home LiteratureArticle Details
PMID: 978319 Published · ppublish English Case Reports Journal Article

Deficiency of adenosine deaminase not associated with severe combined immunodeficiency.

The Journal of pediatrics ·Vol. 89 ·No. 5 ·1976-11-00 ·Pages 732-6

Jenkins T, Rabson AR, Nurse GT, Lane AB

Abstract

The 12-year-old Kung (""Bushman'') boy from South West Africa who has marked deficiency of red cell adenosine deaminase has been found to have 2 to 3% of enzyme activity in red blood cells, 10 to 12% in leukocytes, and 10 to 30% in cultured fibroblasts. The enzyme has ADA 1 electrophoretic mobility: SV40 transformation of cultured fibroblasts caused a decrease of ""tissue ADA'' and an increase in ""red cell ADA'' isozymes. A battery of investigations revealed that the child has normal humoral and cellular immunity. A family study showed that a sibling had the same level of red cell ADA and the parents had intermediate levels. Studies of the Kung population from which the child comes have shown that the allele responsible for the condition, and which we designate ADA8, is polymorphic.

MeSH Terms
Adenosine Deaminase/analysis,blood,deficiency Adult Antibodies/analysis Child Ethnicity Female Genes Humans Immunologic Deficiency Syndromes/genetics Leukocytes Lymphocyte Activation Male Nucleoside Deaminases/deficiency Pedigree Skin Tests South Africa
Chemicals
Antibodies Nucleoside Deaminases Adenosine Deaminase
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Jenkins T
Rabson A R
Nurse G T
Lane A B
Article Info
Journal
The Journal of pediatrics
Abbr.
J Pediatr
ISSN
0022-3476
Published
1976-11-00
Pages
732-6
Language
English
Region
United States
NLM ID
0375410
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com